2024
Attributes of higher- and lower-performing hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) program implementation: A multiple-case study
Stevens E, Fawole A, Rostam Abadi Y, Fernando J, Appleton N, King C, Mazumdar M, Shelley D, Barron C, Bergmann L, Siddiqui S, Schatz D, McNeely J. Attributes of higher- and lower-performing hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) program implementation: A multiple-case study. Journal Of Substance Use And Addiction Treatment 2024, 168: 209528. PMID: 39343141, DOI: 10.1016/j.josat.2024.209528.Peer-Reviewed Original ResearchLower-performing hospitalsOpioid use disorderStepped-wedge cluster randomized controlled trialCluster randomized controlled trialGeneral careHigher-performing hospitalsNew York City's public hospital systemOpioid use disorder treatment programsHigh-performing hospitalsPublic hospital systemAddiction consult servicesPost-discharge medicationUse disorderMultiple-case study designAddiction treatmentRandomized controlled trialsProvider staffingFacility characteristicsHospital systemIndicators of awarenessImplementation periodProgram implementationStudy designCareBuy-inSelf-Reported Methamphetamine Use Versus Biological Testing Among Treatment-Seeking Patients
Gholami J, Ardeshir M, Rostam-Abadi Y, Baheshmat S, Shadloo B, Rahimi-Movaghar A. Self-Reported Methamphetamine Use Versus Biological Testing Among Treatment-Seeking Patients. Iranian Journal Of Psychiatry And Behavioral Sciences 2024, 18 DOI: 10.5812/ijpbs-148330.Peer-Reviewed Original ResearchNegative predictive valuePositive percent agreementMethamphetamine use disorderMethamphetamine useTreatment-seeking patientsSelf-reported useCohen's kappa statisticUrine testsUse disorderPercent agreementKappa statisticNo significant factorsCross-sectional studyDrug treatment centersMonitoring treatmentPredictive valueMethamphetaminePatientsImmunoassay techniqueTreatment-seekingTreatment centersUrinalysisUrineAddiction studiesTreatmentAlcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review
Rostam‐Abadi Y, Gholami J, Shadloo B, Aghaei A, Jobehdar M, Ardeshir M, Sangchooli A, Amin‐Esmaeili M, Taj M, Saeed K, Rahimi‐Movaghar A. Alcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review. Addiction 2024, 119: 984-997. PMID: 38356084, DOI: 10.1111/add.16444.Peer-Reviewed Original ResearchConceptsAdult general populationGeneral populationAlcohol useEastern Mediterranean RegionWorld Health OrganizationAlcohol use disorderPrevalence of alcohol use disordersYoung general populationHealth OrganizationEastern Mediterranean countriesPatterns of alcohol usePublic health impactUse disorderHeavy episodic drinkingEstimates of alcoholAlcohol consumptionPooled prevalencePooled estimatesSystematic reviewHealth impactsEpisodic drinkingHeavy drinkingSubstance useTreatment-seeking peoplePrevalence
2023
Six-Year Follow-up of People Who Use Methamphetamine in Iran: A Case Series Study
Mohammad Aghaei A, Gholami J, Amin-Esmaeili M, Baheshmat S, Rostam-Abadi Y, Rahimi-Movaghar A. Six-Year Follow-up of People Who Use Methamphetamine in Iran: A Case Series Study. International Journal Of High Risk Behaviors And Addiction 2023, 12 DOI: 10.5812/ijhrba-131659.Peer-Reviewed Original ResearchMethamphetamine useIranian Mental Health SurveyFollow-up of peopleSubstance use treatment servicesMental Health SurveyCase series studyFrequency of methamphetamine useHealth care treatmentSix-year follow-upUse disorderSeries studyMethamphetamine use disorderHealth SurveyCompleted interviewsAdverse eventsStudy participantsTreatment servicesEligible casesRate of adverse eventsCare treatmentParticipantsProspective studyTwo-thirdsIncidence of adverse eventsInterviewsDrug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review
Rostam-Abadi Y, Gholami J, Jobehdar M, Ardeshir M, Aghaei A, Olamazadeh S, Taj M, Saeed K, Mojtabai R, Rahimi-Movaghar A. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review. The Lancet Psychiatry 2023, 10: 282-295. PMID: 36848914, DOI: 10.1016/s2215-0366(22)00435-7.Peer-Reviewed Original ResearchConceptsDrug use disordersEastern Mediterranean RegionDrug useTreatment servicesUse disorderIncreasing global public health concernCost-effective carePrevalence of drug use disordersGlobal public health concernPublic health concernPrevalence of drug useGrey literaturePatterns of drug useOpioid agonist treatmentEvidence-basedSystematic reviewTreatment coverageHealth concernAgonist treatmentRegional levelYoung peoplePrevalenceOnline databasesDrugLimited data
2022
Mortality and negative outcomes of opioid use and opioid use disorder: a 6‐year follow‐up study
Gholami J, Baheshmat S, Rostam‐Abadi Y, Hamzehzadeh M, Mojtabai R, Rahimi‐Movaghar A, Amin‐Esmaeili M. Mortality and negative outcomes of opioid use and opioid use disorder: a 6‐year follow‐up study. Addiction 2022, 117: 2059-2066. PMID: 35037359, DOI: 10.1111/add.15805.Peer-Reviewed Original ResearchConceptsComposite International Diagnostic InterviewOutcomes of opioid use disorderOpioid use disorderOpioid useDeath registration systemFollow-up studyWeighted incidence rateMiddle-income countriesAdverse outcomesNegative consequences of opioid useUse disorderFollow-up interviewsCohort of individualsOutcomes of opioid useConsequences of opioid useHealth outcomesFollow-upVital statusAssociated with increased mortalityTelephone callsDiagnostic InterviewRegistration systemPopulation-wereDeath rateHousehold surveyPrevalence, pattern, and associated factors of alcohol use disorder among male treatment-seeking people with illicit drug use disorder in Tehran, Iran
Rafiemanesh H, Rahimi-Movaghar A, Shadloo B, Rostam-Abadi Y, Nedjat S, Yazdani K. Prevalence, pattern, and associated factors of alcohol use disorder among male treatment-seeking people with illicit drug use disorder in Tehran, Iran. Journal Of Substance Use 2022, 28: 211-216. DOI: 10.1080/14659891.2021.2020346.Peer-Reviewed Original ResearchAlcohol use disorderIllicit drug use disordersFactors of alcohol use disorderDrug use disordersUse disorderComorbid alcoholLifetime prevalence of alcohol dependenceAlcohol dependencePrevalence of alcohol use disordersAssociated with alcohol use disorderAssess alcohol use disorderHazardous useResidential drug treatment centerPrevalence of alcohol dependenceLogistic regression analysisMultivariate regression analysisComposite International Diagnostic InterviewCross-sectional studyRegression analysisMale patientsTreatment-seeking peopleDrug treatment centersAlcohol moduleTreatment-seeking individualsLifetime prevalence
2021
Public health risks associated with methadone in Iran: A systematic review and meta-analysis
Rostam-Abadi Y, Gholami J, Noroozi A, Ansari M, Baheshmat S, Hamzehzadeh M, Ghadirzadeh M, Vahdani B, Ekhtiari H, Mojtabai R, Rahimi-Movaghar A. Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal Of Drug Policy 2021, 100: 103529. PMID: 34826790, DOI: 10.1016/j.drugpo.2021.103529.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentNon-prescribed useMethadone useSystematic reviewGeneral populationPositive health outcomesUse disorderFemale general populationSystematic review of studiesSixty-five studiesRandom-effects modelLegal Medicine OrganizationMethadone maintenance treatment programsPublic health concernHealth outcomesSubstance-related deathsReview of studiesPooled proportionCases of acute poisoningMaintenance treatmentMedicine organizationsDrug treatment centersIranian databasesAdverse outcomesPrescription opioidsEvidence for an increase in cannabis use in Iran – A systematic review and trend analysis
Rostam-Abadi Y, Gholami J, Amin-Esmaeili M, Baheshmat S, Hamzehzadeh M, Rafiemanesh H, Nasserbakht M, Ghalichi L, Safarcherati A, Taremian F, Mojtabai R, Rahimi-Movaghar A. Evidence for an increase in cannabis use in Iran – A systematic review and trend analysis. PLOS ONE 2021, 16: e0256563. PMID: 34460847, PMCID: PMC8404985, DOI: 10.1371/journal.pone.0256563.Peer-Reviewed Original ResearchConceptsCannabis use disorderCannabis useUse disorderPrevalence of cannabis use disorderTrends of cannabis usePrevalence of cannabis useGeneral populationPrevalence estimatesHigh-risk groupIranian general populationRandom-effects modelPooled prevalence estimatePooled prevalenceYouth groupsCannabisA systematic reviewSex subgroupsIllicit substancesIranian databasesPrevalenceSystematic reviewNational studyFemale university studentsDisordersMaleComparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder
Shadloo B, Baheshmat S, Rostam-Abadi Y, Shakeri A, Gholami J, Rahimi-Movaghar A. Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder. Journal Of Substance Use And Addiction Treatment 2021, 134: 108555. PMID: 34210569, DOI: 10.1016/j.jsat.2021.108555.Peer-Reviewed Original ResearchConceptsOpioid use disorderSelf-reported opioid useOpioid usePositive percent agreementUrine testsTreatment-seeking patientsCohen's kappa statisticPercent agreementUse disorderKappa statisticNegative predictive valueLonger treatment durationMonitoring treatment adherenceRandom urine testingResults of urinalysisValidity of self-reported drug useCross-sectional studySelf-reported substance useSelf-reported drug useTreatment durationOpioidPredictive valuePatientsTreatment adherenceDrug use